Primary care program to reduce overdose risk in teens and young adults
A Universal Primary Care Based Pilot Intervention to Reduce Youth Overdose Risk
This program will try brief overdose-prevention counseling and naloxone information in primary care to see if it lowers overdose risk for teens and young adults ages 13–26.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 24 (estimated) |
| Ages | 13 Years and up |
| Sex | All |
| Sponsor | Boston Medical Center Academic / other |
| Locations | 1 site (Boston, Massachusetts) |
| Trial ID | NCT07022717 on ClinicalTrials.gov |
What this trial studies
Primary care clinicians at Boston Medical Center deliver a brief youth-focused overdose prevention education session and provide information about naloxone during routine comprehensive physicals, compared with usual care. Participating clinicians are pediatric or family medicine physicians and advanced practice providers who see patients at least twice weekly. Eligible youth are English-speaking patients aged 13–26 scheduled with a participating provider; caregivers must be able to consent for minors. The intervention leverages trusted provider relationships in primary care to introduce harm reduction content in a developmentally appropriate way.
Who should consider this trial
Good fit: Ideal participants are English-speaking teens and young adults ages 13–26 who are scheduled for a comprehensive physical with a participating pediatric or family medicine clinician at Boston Medical Center, and clinicians who work at least two clinic sessions per week.
Not a fit: Patients who are non-English speakers, under Department of Children and Families custody, have significant cognitive limitations as judged by their provider, or are in acute psychiatric distress may not benefit from this program.
Why it matters
Potential benefit: If successful, the program could increase naloxone awareness and safer behaviors and reduce fatal and nonfatal overdoses among youth.
How similar studies have performed: Similar brief overdose-prevention and naloxone-distribution efforts have reduced overdose and been cost-effective in adults, but evidence for dedicated youth-focused primary care interventions is limited.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria for providers: * Physicians and advance practice providers within Pediatric Primary Care and Family Medicine at Boston Medical Center (BMC) * ≥ 2 clinic sessions per/week Exclusion Criteria for providers: * None Inclusion criteria for youth: * Ages 13-26 * Scheduled for a comprehensive physical exam with a provider who is participating in the trial * English speaking Exclusion criteria for youth: * Caregivers of youth ages 13-17 unable to provide informed consent or are not English speaking * Cognitive limitation or intellectual disability that in the opinion of their provider would not * Any medical/psychiatric condition that causes acute distress and requires emergency evaluation * Under legal custody of the Department of Children and Families (DCF)
Where this trial is running
Boston, Massachusetts
- Boston Medical Center, Pediatric Primary Care & Family Medicine — Boston, Massachusetts, United States (Recruiting)
Study contacts
- Principal investigator: Sarah Bagley, MD MSc — Boston Medical Center, Internal Medicine, Addiction Medicine
- Study coordinator: Sarah Bagley, MD MSc
- Email: sarah.bagley@bmc.org
- Phone: 617 414 6906
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.